Recently, parabens have been believed to act as xenoestrogens, an identified class of endocrine disruptors (EDs). These environmental compounds are the most well-known as preservatives in many commercial products, including food, cosmetics and pharmaceutical industries. It has been demonstrated that...
Recently, parabens have been believed to act as xenoestrogens, an identified class of endocrine disruptors (EDs). These environmental compounds are the most well-known as preservatives in many commercial products, including food, cosmetics and pharmaceutical industries. It has been demonstrated that the human health risks of parabens result from a long-term exposure to skin in which this chemical group is rapidly absorbed through the skin. On the other hand, parabens are also completely absorbed from gastrointestinal tract. It has reported that these substances possess several biological effects in which inhibitory property involved in membrane transports and mitochondrial functions is considered to be important for their action. Testing of parabens has revealed that estrogen-like activities of these chemicals are much less potent than natural estrogen, $17{\beta}$ estradiol (E2). Additionally, the estrogenicity of individual paraben- compounds is distinct depending upon their biochemical structure. Recent findings of paraben-estrogenic activities have shown that these compounds may affect breast cancer incidence in women, suggesting adverse ecological outcomes of this environmental group on human and animal health. Although the biological and toxicological effects of parabens have been demonstrated in many previous studies, possible mechanism(s) of their action are required to be explored in order to bring the better understanding in the detrimental impacts of parabens in human and wildlife. There have several different types of parabens which are the most widely used as preservatives. These include methyl-paraben, ethylparaben, propylparaben, butylparaben and p-hydroxybenzoic acid, a major metabolite of parabens. In this review, we summarize current database based on in vitro and in vivo assays for estrogenic activities and health risk assessment of paraben- EDs which have been published previously.
Recently, parabens have been believed to act as xenoestrogens, an identified class of endocrine disruptors (EDs). These environmental compounds are the most well-known as preservatives in many commercial products, including food, cosmetics and pharmaceutical industries. It has been demonstrated that the human health risks of parabens result from a long-term exposure to skin in which this chemical group is rapidly absorbed through the skin. On the other hand, parabens are also completely absorbed from gastrointestinal tract. It has reported that these substances possess several biological effects in which inhibitory property involved in membrane transports and mitochondrial functions is considered to be important for their action. Testing of parabens has revealed that estrogen-like activities of these chemicals are much less potent than natural estrogen, $17{\beta}$ estradiol (E2). Additionally, the estrogenicity of individual paraben- compounds is distinct depending upon their biochemical structure. Recent findings of paraben-estrogenic activities have shown that these compounds may affect breast cancer incidence in women, suggesting adverse ecological outcomes of this environmental group on human and animal health. Although the biological and toxicological effects of parabens have been demonstrated in many previous studies, possible mechanism(s) of their action are required to be explored in order to bring the better understanding in the detrimental impacts of parabens in human and wildlife. There have several different types of parabens which are the most widely used as preservatives. These include methyl-paraben, ethylparaben, propylparaben, butylparaben and p-hydroxybenzoic acid, a major metabolite of parabens. In this review, we summarize current database based on in vitro and in vivo assays for estrogenic activities and health risk assessment of paraben- EDs which have been published previously.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
제안 방법
In this review, we survey current databases containing information on the in vitro and in vivo estrogenicity of parabens as well previous publications dealing with the health risks associated with these compounds. The information provided here may be of importance when it becomes necessary to reconsider the use of parabens as preservatives in food, cosmetics and in the pharmaceutical industries.
후속연구
, 2000). Further analysis is needed to acquire a better understanding of the estrogenic effects of propylparaben in vivo.
Recent critical evidence has shown that several parabens accumulate in breast tumor tissue, indicating the potential risk of these estrogenic EDs for breast cancer. Further studies are required to elucidate the molecular and biochemical mechanism(s) underlying the possible harmful effects of paraben exposure in human and animals, particularly during the critical developmental stages in these organisms.
The information provided here may be of importance when it becomes necessary to reconsider the use of parabens as preservatives in food, cosmetics and in the pharmaceutical industries. Furthermore, new research will be required to obtain new insighte into the mechanism(s) through which EDs elicit their effects on biological systems and on human and animal health.
참고문헌 (65)
An BS, Choi KC, Kang SK, Hwang WS and Jeung EB. 2003. Novel Calbindin-D(9k) protein as a useful biomarker for environmental estrogenic compounds in the uterus of immature rats. Reprod. Toxicol. 17:311-319
An BS, Kang SK, Shin JH and Jeung EB. 2002. Stimulation of calbindin-D(9k) mRNA expression in the rat uterus by octyl-phenol, nonylphenol and bisphenol. Mol. Cell. Endocrinol. 191:177-186
Bando H, Mohri S, Yamashita F, Takakura Y and Hashida M. 1997. Effects of skin metabolism on percutaneous penetration of lipophilic drugs. J. Pharm. Sci. 86:759-761
Bardin A, Boulle N, Lazennec G, Vignon F and Pujol P. 2004. Loss of ERbeta expression as a common step in estrogendependent tumor progression. Endocr. Relat. Cancer. 11:537-551
Bulger WH, Muccitelli RM and Kupfer D. 1978. Interactions of methoxychlor, methoxychlor base-soluble contaminant, and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane with rat uterine estrogen receptor. J. Toxicol. Environ. Health. 4:881-893
Byford JR, Shaw LE, Drew MG, Pope GS, Sauer MJ and Darbre PD. 2002. Oestrogenic activity of parabens in MCF7 human breast cancer cells. J. Steroid. Biochem. Mol. Biol. 80:49-60
Choi SM and Lee BM. 2004. An alternative mode of action of endocrine-disrupting chemicals and chemoprevention. J. Toxicol. Environ. Health. B. Crit. Rev. 7:451-463
Cupp AS and Skinner MK. 2001. Actions of the endocrine disruptor methoxychlor and its estrogenic metabolite on in vitro embryonic rat seminiferous cord formation and perinatal testis growth. Reprod. Toxicol. 15:317-326
Dang VH, Choi KC and Jeung EB. 2007c. Tetrabromodiphenyl ether (BDE 47) evokes estrogenicity and calbindin-D9k expression through an estrogen receptor-mediated pathway in the uterus of immature rats. Toxicol. Sci. 97:504- 511
Dang VH, Choi KC, Hyun SH and Jeung EB. 2007a. Analysis of gene expression profiles in the offspring of rats following maternal exposure to xenoestrogens. Reprod. Toxicol. 23:42-54
Dang VH, Choi KC, Hyun SH and Jeung EB. 2007b. Induction of uterine calbindin-d9k through an estrogen receptordependent pathway following single injection with xenobiotic agents in immature rats. J. Toxicol. Environ. Health. A. 70:171-182
Dang VH, Nguyen TH, Choi KC and Jeung EB. 2007d. A calcium-binding protein, calbindin-D9k, is regulated through an estrogen-receptor-mediated mechanism following xenoestrogen exposure in the GH3 cell line. Toxicol. Sci. 98: 408-415
Dang VH, Nguyen TH, Choi KC and Jeung EB. 2007e. Unexpected estrogenicity of endocrine disruptors may evoke a failure of pregnancy derived from uterine function: Overview of their possible mechanism(s) through steroid receptors. J. Emb. Trans. 22:199-208
Danzo BJ. 1997. Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. Environ. Health. Perspect. 105:294-301
Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ and Pope GS. 2004. Concentrations of parabens in human breast tumours. J. Appl. Toxicol. 24:5-13
Darbre PD, Byford JR, Shaw LE, Horton RA, Pope GS and Sauer MJ. 2002. Oestrogenic activity of isobutylparaben in vitro and in vivo. J. Appl. Toxicol. 22:219-226
Daston GP. 2004. Developmental toxicity evaluation of butylparaben in Sprague-Dawley rats. Birth. Defects. Res. B. Dev. Reprod. Toxicol. 71: 96-302
DeRosa C, Richter P, Pohl H and Jones DE. 1998. Environmental exposures that affect the endocrine system: public health implications. J. Toxicol. Environ. Health. B. Crit.Rev. 1:3-26
Elsby R, Maggs JL, Ashby J and Park BK. 2001a. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J. Pharmacol. Exp. Ther. 297:103-113
Elsby R, Maggs JL, Ashby J, Paton D, Sumpter JP and Park BK. 2001b. Assessment of the effects of metabolism on the estrogenic activity of xenoestrogens: a two-stage approach coupling human liver microsomes and a yeast estrogenicity assay. J. Pharmacol. Exp. Ther. 296:329-337
Gardner RM, Verner G, Kirkland JL and Stancel GM. 1989. Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle. J. Steroid. Biochem. 32:339-343
Golden R, Gandy J and Vollmer G. 2005. A review of the endocrine activity of parabens and implications for potential risks to human health. Crit. Rev. Toxicol. 35:435-458
Gould JC, Leonard LS, Maness SC, Wagner BL, Conner K, Zacharewski T, Safe S, McDonnell DP and Gaido KW. 1998. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol. Cell. Endocrinol. 142:203-214
Gray LE Jr, Kelce WR, Wiese T, Tyl R, Gaido K, Cook J, Klinefelter G, Desaulniers D, Wilson E, Zacharewski T, Waller C, Foster P, Laskey J, Reel J, Giesy J, Laws S, Mc- Lachlan J, Breslin W, Cooper R, Di Giulio R, Johnson R, Purdy R, Mihaich E, Safe S, Colborn T and et al. 1997. Endocrine screening methods workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod. Toxicol. 11:719-750
Harvey PW and Darbre P. 2004. Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? J. Appl. Toxicol. 24:167-176
Heppell SA, Denslow ND, Folmar LC and Sullivan CV. 1995. Universal assay of vitellogenin as a biomarker for environmental estrogens. Environ. Health. Perspect. 103 Suppl 7: 9-15
Hong EJ, Choi KC and Jeung EB. 2003. Maternal-fetal transfer of endocrine disruptors in the induction of calbindin- D9k mRNA and protein during pregnancy in rat model. Mol. Cell. Endocrinol. 212:63-72
Hong EJ, Choi KC and Jeung EB. 2004a. Induction of calbindin- D9k messenger RNA and protein by maternal exposure to alkylphenols during late pregnancy in maternal and neonatal uteri of rats. Biol. Reprod. 71:669-675
Hong EJ, Choi KC and Jeung EB. 2005. Maternal exposure to bisphenol a during late pregnancy resulted in an increase of calbindin-D9k mRNA and protein in maternal and postnatal rat uteri. J. Reprod. Dev. 51:499-508
Hong EJ, Choi KC, Jung YW, Leung PC and Jeung EB. 2004b. Transfer of maternally injected endocrine disruptors through breast milk during lactation induces neonatal calbindin-D9k in the rat model. Reprod. Toxicol. 18:661-668
Hossaini A, Larsen JJ and Larsen JC. 2000. Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays. Food. Chem. Toxicol. 38:319-323
Laws SC, Carey SA, Ferrell JM, Bodman GJ and Cooper RL. 2000. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol. Sci. 54:154-167
Lemini C, Silva G, Timossi C, Luque D, Valverde A, Gonzalez- Martinez M, Hernandez A, Rubio-Poo C, Chavez Lara B and Valenzuela F. 1997. Estrogenic effects of p-hydroxybenzoic acid in CD1 mice. Environ. Res. 75:130-134
Lobemeier C, Tschoetschel C, Westie S and Heymann E. 1996. Hydrolysis of parabenes by extracts from differing layers of human skin. Biol. Chem. 377:647-651
McKinney JD and Waller CL. 1998. Molecular determinants of hormone mimicry: halogenated aromatic hydrocarbon environmental agents. J. Toxicol. Environ. Health. B. Crit. Rev. 1:27-58
Mukku VR and Stancel GM. 1985. Regulation of epidermal growth factor receptor by estrogen. J. Biol. Chem. 260: 9820-9824
Nelson KG, Takahashi T, Bossert NL, Walmer DK and McLachlan JA. 1991. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc. Natl. Acad. Sci. USA. 88:21-25.
Newbold RR, Jefferson WN, Padilla-Banks E and Haseman J. 2004. Developmental exposure to diethylstilbestrol (DES) alters uterine response to estrogens in prepubescent mice: low versus high dose effects. Reprod. Toxicol. 18:399-406
Okubo T, Yokoyama Y, Kano K and Kano I. 2001. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR. Food. Chem. Toxicol. 39:1225-1232
Owens JW and Ashby J. 2002. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development. Crit. Rev. Toxicol. 32:445-520
Pedersen KL, Pedersen SN, Christiansen LB, Korsgaard B and Bjerregaard P. 2000. The preservatives ethyl-, propyl- and butylparaben are oestrogenic in an in vivo fish assay. Pharmacol. Toxicol. 86:110-113
Prusakiewicz JJ, Harville HM, Zhang Y, Ackermann C and Voorman RL. 2007. Parabens inhibit human skin estrogen sulfotransferase activity: possible link to paraben estrogenic effects. Toxicology 232:248-256
Rastogi SC, Schouten A, de Kruijf N and Weijland JW. 1995. Contents of methyl-, ethyl-, propyl-, butyl- and benzylparaben in cosmetic products. Contact. Dermatitis. 32:28-30
Ren L, Marquardt MA and Lech JJ. 1997. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7. Chem. Biol. Interact. 104:55-64
Riggs BL and Hartmann LC. 2003. Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. N. Engl. J. Med. 348:618-629
Roy D, Palangat M, Chen CW, Thomas RD, Colerangle J, Atkinson A and Yan ZJ. 1997. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. J. Toxicol. Environ. Health. 50:1-29
Soni MG, Burdock GA, Taylor SL and Greenberg NA. 2001. Safety assessment of propyl paraben: a review of the published literature. Food. Chem. Toxicol. 39:513-532
Soni MG, Taylor SL, Greenberg NA and Burdock GA. 2002. Evaluation of the health aspects of methyl paraben: a review of the published literature. Food. Chem. Tox[icol. 40: 1335-1373
Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N and Serrano FO. 1995. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health. Perspect. 103 Suppl 7:113-122
Stellman SD, Djordjevic MV, Muscat JE, Gong L, Bernstein D, Citron ML, White A, Kemeny M, Busch E and Nafziger AN. 1998. Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. Cancer. Epidemiol. Biomarkers. Prev. 7:489-496
Turusov V, Rakitsky V and Tomatis L. 2002. Dichlorodiphenyltrichloroethane (DDT): ubiquity, persistence, and risks. Environ. Health. Perspect. 110:125-128
Upmeier A, Degen GH, Schuhmacher US, Certa H and Bolt HM. 1999. Toxicokinetics of p-tert-octylphenol in female DA/Han rats after single i.v. and oral application. Arch. Toxicol. 73: 217-222
Watanabe H, Suzuki A, Kobayashi M, Takahashi E, Itamoto M, Lubahn DB, Handa H and Iguchi T. 2003. Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus. J. Mol. Endocrinol. 30:347-358
Wilson ME, Price RH, Jr and Handa RJ. 1998. Estrogen receptor- beta messenger ribonucleic acid expression in the pituitary gland. Endocrinology 139: 5151-5156
※ AI-Helper는 부적절한 답변을 할 수 있습니다.